Lockheed Martin: Problems Are Piling Up
https://seekingalpha.com/article/4671772-lockheed-martin-problems-are-piling-up?source=feed_all_articles
Feb 20, 2024 - Lockheed Martin's stock has declined since the initial jump following the Russian invasion of Ukraine. Learn why LMT is a Hold.
0
CyberArk Proved Its Subscription Transition Worked, But The Stock Has Kept Up
https://seekingalpha.com/article/4671649-cyberark-proved-its-subscription-transition-worked-but-the-stock-has-kept-up?source=feed_tag_israel
Feb 20, 2024 - While I've been invested in CyberArk since the low-to-mid $100s, now is not the time to add to my position. Learn why I rate CYBR stock a hold.
0
SciSparc shares up on patents filed for psychedelic compounds with Clearmind
https://seekingalpha.com/news/4068940-scisparc-shares-up-on-patents-filed-for-psychedelic-compounds-with-clearmind?source=feed_tag_israel
Feb 20, 2024 - SciSparc shares surge 45% as Clearmind Medicine files three patent applications for psychedelic drug combinations.
0
Post Holdings (POST) Up More Than 20% in 3 Months: Here's Why
https://www.zacks.com/stock/news/2228762/post-holdings-post-up-more-than-20-in-3-months-here-s-why?cid=CS-ZC-FT-analyst_blog|rank_focused-2228762
Feb 20, 2024 - Post Holdings (POST) is benefiting from effective pricing actions and contributions from its prudent acquisitions.
0
Medtronic (MDT) Q3 Earnings Beat Estimates, 2024 View Up
https://www.zacks.com/stock/news/2228769/medtronic-mdt-q3-earnings-beat-estimates-2024-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2228769
Feb 20, 2024 - Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies.
0
Target teams up with Diane von Furstenberg for its next limited-time collection
https://www.startribune.com/target-diane-von-furstenberg-dresses-limited-time-design-collaboration/600344759/
Feb 20, 2024 - The announcement comes days after the Minneapolis-based retailer also announced a new bargain brand as it looks to revive sales.
0
Puma Biotech (PBYI) Is Up 23.01% in One Week: What You Should Know
https://www.zacks.com/stock/news/2229538/puma-biotech-pbyi-is-up-23-01-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2229538
Feb 21, 2024 - Does Puma Biotech (PBYI) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Activist Group Calls for Norfolk Southern (NSC) Board Revamp
https://www.zacks.com/stock/news/2229449/activist-group-calls-for-norfolk-southern-nsc-board-revamp?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2229449
Feb 21, 2024 - Ancora Holdings aims to replace Norfolk Southern's (NSC) current CEO, Alan Shaw, with Jim Barber.
0
Garmin's (GRMN) Q4 Earnings & Sales Beat Estimates, Up Y/Y
https://www.zacks.com/stock/news/2229471/garmin-s-grmn-q4-earnings-sales-beat-estimates-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2229471
Feb 21, 2024 - Garmin's (GRMN) fourth-quarter results benefit from strength in the Outdoor, Fitness, Auto and Marine segments.
0
Why Is Gatx (GATX) Up 1.8% Since Last Earnings Report?
https://www.zacks.com/stock/news/2230337/why-is-gatx-gatx-up-1-8-since-last-earnings-report?cid=CS-ZC-FT-realtime_blog-2230337
Feb 22, 2024 - Gatx (GATX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
Page 1>